Codice QR

Yin-Dan-Ping-Gan Capsule Mitigates CCL<sub>4</sub>-Induced Liver Fibrosis via Regulating PPAR γ/GPX4 Signaling and Suppressing Ferroptosis

<b>Background:</b> Liver fibrosis is a major global public health issue that is only getting worse. The underlying molecular mechanisms of Yindanpinggan Capsule (YDPG), a traditional Chinese medication, are still unknown, although it has shown notable effectiveness in treating fibrosis and other for...

Descrizione completa

Salvato in:
Autori principali: Xue Jiang, Jicheng Yang, Yusheng Zhang, Ying Zhang, Zhen Ouyang, Chen Zhao, Limin Lin, Xianyu Li, Luqi Huang
Natura: Artigo
Lingua:Inglês
Pubblicazione: MDPI AG 2026-02-01
Serie:Pharmaceuticals
Soggetti:
Yindanpinggan Capsule
liver fibrosis
network pharmacology
proteomics
ferroptosis
PPAR γ
Accesso online:https://www.mdpi.com/1424-8247/19/2/251
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi